QNRX Wutah pendapatan triwulanan Quoin Pharma

Simbol lan logo merek Quoin Pharmaceuticals Ltd. (QNRX)

Quoin Pharmaceuticals focuses on patents and the treatment of rare skin pathologies, including Netherton syndrome. The company is developing scientific partnerships with specialized funds to create innovative therapies. Its environmental approach is limited to compliance with laboratory standards. The value of 0.00 shows the current figure visualized by the QoQ revenue growth rate on this chart.

QNRX Wutah dodolan kuartal marang kuartal quoinpharma.com (04.07.2022 - 21.11.2026)

Rincian metrik komprehensif lan analitis Quoin Pharma (QNRX)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:Quoin Pharmaceuticals Ltd. (QNRX)
Produk seri Quoin Pharmaceuticals Ltd

To filter blue-chip assets, investors utilize revenue dynamics as a marker of operational efficiency and market expectations. The QoQ revenue growth metric measures the percentage change in sales between consecutive quarters, which for Quoin Pharmaceuticals (QNRX), currently in the clinical scaling stage of drugs for rare skin diseases, reflects the pace of commercialization and the success of partnerships with pharma behemoths.